Recent Posts
- CAL101 treatment for scarring safe, well tolerated in Phase 1 trial
- Low ‘good’ cholesterol levels linked to more severe SSc-ILD
- Chest CT scan before transplant may predict survival after: Study
- SRF announces lineup for Cool Comedy, Hot Cuisine fundraiser
- Immune system’s toll-like receptor 8 may be SSc therapeutic target
- Certa’s SSc treatment candidate FT011 now known as asengeprast
- Antibodies vary by race, but don’t explain differences in scleroderma
- Profervia granted FDA orphan drug status as treatment for SSc
- Blood TSLP protein linked to greater risk of digital ulcers in SSc: Study
- Letairis may prevent PAH linked to scleroderma: Study